RI Bio - Page 6 of 6 - Providence Business News

Home Tags RI Bio

BROADENED MISSION: Carol Malysz, executive director of Providence-based biotechnology trade association RI BIO, said the group has broadened its focus. Previously known as MedMates, this year the company changed its name and approach to promote the entire biotech industry.  / PBN PHOTO/MICHAEL SALERNO

Ocean State starting to see growth in biotech industry

Focus 06/28/2019

RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...

RI Bio names new board of directors member, board chair emeritus

Health Services 02/18/2019

PROVIDENCE – Life sciences industry group RI Bio has named a new member to its board of directors as well as a new board...

RI BIO AND the Rhode Island BioHub Group’s collaborative report on the state’s life sciences industry indicated that the sector was held back by fragmented and uncoordinated resources. The report also recommended RI Bio as an organizing force among other suggestions intended to help the industry reach its potential in Rhode Island.

RI Bio, Rhode Island BioHub Group chart local life science industry...

Health Services 01/28/2019

PROVIDENCE — The state’s life sciences industry has been held back by fragmented and uncoordinated resources, according to a collaborative report from the biotechnology...

MEDMATES HAS REBRANDED as RI Bio and is selling memberships with new services made available through their affiliation with the international trade group Biotechnology Innovation Organization.

MedMates rebrands as RI Bio, introduces membership fees

Health Services 01/15/2019

PROVIDENCE — Local life sciences industry network group MedMates has rebranded as RI Bio, is now the Rhode Island affiliate of Biotechnology Innovation Organization,...

1...4 56Page 6 of 6

- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.